Salomon & Ludwin’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25.7K Sell
305
-264
-46% -$23.1K ﹤0.01% 965
2026
Q1
$51.7K Buy
569
+274
+93% +$25.1K ﹤0.01% 467
2025
Q4
$27.3K Hold
295
﹤0.01% 668
2025
Q3
$29.7K Hold
295
﹤0.01% 585
2025
Q2
$27.6K Hold
295
﹤0.01% 342
2025
Q1
$33.4K Hold
295
﹤0.01% 295
2024
Q4
$31.2K Hold
295
﹤0.01% 296
2024
Q3
$31.8K Hold
295
﹤0.01% 309
2024
Q2
$32K Sell
295
-10
-3% -$1.18K ﹤0.01% 308
2024
Q1
$40.3K Hold
305
﹤0.01% 389
2023
Q4
$34.2K Hold
305
﹤0.01% 351
2023
Q3
$34.2K Buy
+305
New +$38.7K ﹤0.01% 351

Other funds holding ZBH

Salomon & Ludwin's ZBH Position: Q2 2026 in Review

Salomon & Ludwin reduced its Zimmer Biomet (ZBH) stake by 46% in Q2 2026, selling an estimated $23.1K and leaving 305 shares worth $25.7K. The position accounts for ﹤0.01% of the portfolio, ranked #965.

Salomon & Ludwin first reported a position in ZBH in Q3 2023 and has held it in 12 quarters since. The position peaked at $51.7K in Q1 2026. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Salomon & Ludwin held 305 shares of Zimmer Biomet worth $25.7K as of Q2 2026.
  • Salomon & Ludwin sold 264 Zimmer Biomet shares in Q2 2026, an estimated $23.1K.
  • Zimmer Biomet made up ﹤0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #965 holding.
  • Salomon & Ludwin first reported a position in Zimmer Biomet in Q3 2023 and has held it in 12 quarters since.
  • Salomon & Ludwin's Zimmer Biomet position peaked at $51.7K in Q1 2026.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.